These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39339898)

  • 1. Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy.
    Armenia D; Carioti L; Micheli V; Bon I; Allice T; Bonura C; Bruzzone B; Bracchitta F; Cerutti F; Giammanco GM; Stefanelli F; Bonifacio MA; Bertoli A; Vatteroni M; Ibba G; Novazzi F; Lipsi MR; Cuomo N; Vicenti I; Ceccherini-Silberstein F; Rossetti B; Bezenchek A; Saladini F; Zazzi M; Santoro MM;
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparison of Sanger Sequencing and Amplicon-Based Next Generation Sequencing Approaches for the Detection of HIV-1 Drug Resistance Mutations.
    Biba C; Fiaschi L; Varasi I; Paletti C; Bartolini N; Zazzi M; Vicenti I; Saladini F
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients.
    Alidjinou EK; Deldalle J; Hallaert C; Robineau O; Ajana F; Choisy P; Hober D; Bocket L
    J Antimicrob Chemother; 2017 Oct; 72(10):2823-2830. PubMed ID: 29091197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of an
    Tzou PL; Ariyaratne P; Varghese V; Lee C; Rakhmanaliev E; Villy C; Yee M; Tan K; Michel G; Pinsky BA; Shafer RW
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.
    Alidjinou EK; Coulon P; Hallaert C; Robineau O; Meybeck A; Huleux T; Ajana F; Hober D; Bocket L
    J Clin Virol; 2019 Dec; 121():104207. PubMed ID: 31707202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Aspects of the Virus Life Cycle and Clinical Utility of Next Generation Sequencing based HIV-1 Resistance Testing in the Genomic, the Proviral, and the Viral Reservoir of Peripheral Blood Mononuclear Cells.
    Pröll J; Paar C; Taylor N; Skocic M; Freystetter A; Blaimschein A; Mayr R; Niklas N; Atzmüller S; Raml E; Wechselberger C
    Curr HIV Res; 2022; 20(3):213-221. PubMed ID: 35331114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-efficient HIV-1 drug resistance surveillance using multiplexed high-throughput amplicon sequencing: implications for use in low- and middle-income countries.
    Ekici H; Rao SD; Sönnerborg A; Ramprasad VL; Gupta R; Neogi U
    J Antimicrob Chemother; 2014 Dec; 69(12):3349-55. PubMed ID: 25085657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of publicly-available software used in analyzing NGS data for HIV-1 drug resistance mutations and transmission networks in a Washington, DC, Cohort.
    Jair K; McCann CD; Reed H; Castel AD; Pérez-Losada M; Wilbourn B; Greenberg AE; Jordan JA;
    PLoS One; 2019; 14(4):e0214820. PubMed ID: 30964884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 genotypic resistance testing using single molecule real-time sequencing.
    Raymond S; Jeanne N; Vellas C; Nicot F; Saune K; Ranger N; Latour J; Carcenac R; Harter A; Delobel P; Izopet J
    J Clin Virol; 2024 Oct; 174():105717. PubMed ID: 39068746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of drug resistance against protease, reverse transcriptase, and integrase inhibitors by next-generation sequencing in HIV-positive patients.
    Tekin D; Gokengin D; Onay H; Erensoy S; Sertoz R
    J Med Virol; 2021 Jun; 93(6):3627-3633. PubMed ID: 33026651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Evaluation of the Vela Diagnostics Next-Generation Sequencing Platform for HIV-1 Genotypic Resistance Testing.
    Weber J; Volkova I; Sahoo MK; Tzou PL; Shafer RW; Pinsky BA
    J Mol Diagn; 2019 Nov; 21(6):961-970. PubMed ID: 31382033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform.
    May S; Adamska E; Tang J
    J Clin Virol; 2020 Jun; 127():104376. PubMed ID: 32344322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the Applied Biosystems HIV-1 Genotyping Kit with Integrase.
    Moore HP; Palumbo PJ; Notarte KI; Fogel JM; Cummings V; Gamble T; Del Rio C; Batey DS; Mayer KH; Farley JE; Remien RH; Beyrer C; Hudelson SE; Eshleman SH;
    J Clin Microbiol; 2024 Jun; 62(6):e0013624. PubMed ID: 38727213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry.
    Armenia D; Spagnuolo V; Bellocchi MC; Galli L; Duca L; Marchegiani G; Clemente T; Carioti L; Lolatto R; Calza L; Celesia BM; Cascio A; Francisci D; Saracino A; Torti C; Zazzi M; Castagna A; Santoro MM;
    J Antimicrob Chemother; 2024 Sep; 79(9):2354-2363. PubMed ID: 39004997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity of HIV-1 Subtypes and Transmitted Drug-resistance Mutations Among Minority HIV-1 Variants in a Turkish Cohort.
    Sarinoglu RC; Sili U; Hasdemir U; Aksu B; Soyletir G; Korten V
    Curr HIV Res; 2022; 20(1):54-62. PubMed ID: 34802406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.
    Raymond S; Nicot F; Carcenac R; Lefebvre C; Jeanne N; Saune K; Delobel P; Izopet J
    J Antimicrob Chemother; 2018 May; 73(5):1152-1157. PubMed ID: 29444253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges.
    Lee ER; Gao F; Sandstrom P; Ji H
    Viruses; 2020 May; 12(5):. PubMed ID: 32429382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation.
    Paredes R; Tzou PL; van Zyl G; Barrow G; Camacho R; Carmona S; Grant PM; Gupta RK; Hamers RL; Harrigan PR; Jordan MR; Kantor R; Katzenstein DA; Kuritzkes DR; Maldarelli F; Otelea D; Wallis CL; Schapiro JM; Shafer RW
    PLoS One; 2017; 12(7):e0181357. PubMed ID: 28753637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Added Value of Next Generation over Sanger Sequencing in Kenyan Youth with Extensive HIV-1 Drug Resistance.
    Novitsky V; Nyandiko W; Vreeman R; DeLong AK; Manne A; Scanlon M; Ngeresa A; Aluoch J; Sang F; Ashimosi C; Jepkemboi E; Orido M; Hogan JW; Kantor R;
    Microbiol Spectr; 2022 Dec; 10(6):e0345422. PubMed ID: 36445146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRESTIGIO RING: "A 59-year-old HIV-1 positive, highly treatment-experienced woman failing darunavir/ ritonavir plus raltegravir".
    Labate L; Bruzzone B; Spagnuolo V; Zazzi M; Santoro MM; Di Biagio A; Castagna A
    New Microbiol; 2023 May; 46(2):226-230. PubMed ID: 37247247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.